Is choline deficiency an unrecognized factor in necrotizing enterocolitis of preterm infants?
Journal
Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714
Informations de publication
Date de publication:
24 Apr 2024
24 Apr 2024
Historique:
received:
07
12
2023
accepted:
15
03
2024
revised:
23
02
2024
medline:
25
4
2024
pubmed:
25
4
2024
entrez:
24
4
2024
Statut:
aheadofprint
Résumé
We undertook this review to determine if it is plausible that choline or phosphatidylcholine (PC) deficiency is a factor in necrotizing enterocolitis (NEC) after two clinical trials found a dramatic and unexpected reduction in NEC in an experimental group provided higher PC compared to a control group. Sources and amounts of choline/PC for preterm infants are compared to the choline status of preterm infants at birth and following conventional nutritional management. The roles of choline/PC in intestinal structure, mucus, mesenteric blood flow, and the cholinergic anti-inflammatory system are summarized. Low choline/PC status is linked to prematurity/immaturity, parenteral and enteral feeding, microbial dysbiosis and hypoxia/ischemia, factors long associated with the risk of developing NEC. We conclude that low choline status exists in preterm infants provided conventional parenteral and enteral nutritional management, and that it is plausible low choline/PC status adversely affects intestinal function to set up the vicious cycle of inflammation, loss of intestinal barrier function and worsening tissue hypoxia that occurs with NEC. In conclusion, this review supports the need for randomized clinical trials to test the hypothesis that additional choline or PC provided parenterally or enterally can reduce the incidence of NEC in preterm infants. IMPACT STATEMENT: Low choline status in preterm infants who are managed by conventional nutrition is plausibly linked to the risk of developing necrotizing enterocolitis.
Identifiants
pubmed: 38658665
doi: 10.1038/s41390-024-03212-5
pii: 10.1038/s41390-024-03212-5
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.
Références
Alsaied, A., Islam, N. & Thalib, L. Global incidence of necrotizing enterocolitis: a systematic review and meta-analysis. BMC Pediatr. 20, 344 (2020).
pubmed: 32660457
pmcid: 7359006
doi: 10.1186/s12887-020-02231-5
Stoll, B. J. et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993–2012. JAMA 314, 1039–1051 (2015).
pubmed: 26348753
pmcid: 4787615
doi: 10.1001/jama.2015.10244
Caplan, M. S., MacKendrick, W. Necrotizing enterocolitis: a review of pathogenetic mechanisms and implications for prevention. Pediatr. Pathol. 13 https://doi.org/10.3109/15513819309048223 (1993).
Wolf, M. F. et al. Trends and racial and geographic differences in infant mortality in the United States due to necrotizing enterocolitis, 1999 to 2020. JAMA Netw. Open 6, e231511 (2023).
pubmed: 36867411
pmcid: 9984971
doi: 10.1001/jamanetworkopen.2023.1511
Patel, R. M. et al. Causes and timing of death in extremely premature infants from 2000 through 2011. N. Engl. J. Med. 372, 331–340 (2015).
pubmed: 25607427
pmcid: 4349362
doi: 10.1056/NEJMoa1403489
Christensen, R. D., Gordon, P. V. & Besner, G. E. Can we cut the incidence of necrotizing enterocolitis in half–today? Fetal Pediatr. Pathol. 29, 185–198 (2010).
pubmed: 20594142
doi: 10.3109/15513815.2010.483874
Patel, A. L. & Kim, J. H. Human milk and necrotizing enterocolitis. Semin. Pediatr. Surg. 27, 34–38 (2018).
pubmed: 29275815
doi: 10.1053/j.sempedsurg.2017.11.007
Fatemizadeh, R. et al. Incidence of spontaneous intestinal perforations exceeds necrotizing enterocolitis in extremely low birth weight infants fed an exclusive human milk-based diet: a single center experience. J. Pediatr. Surg. 56, 1051–1056 (2021).
pubmed: 33092814
doi: 10.1016/j.jpedsurg.2020.09.015
Hintz, S. R. et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 115, 696–703 (2005).
pubmed: 15741374
doi: 10.1542/peds.2004-0569
Duchon, J., Barbian, M. E. & Denning, P. W. Necrotizing Enterocolitis. Clin. Perinatol. 48, 229–250 (2021).
pubmed: 34030811
doi: 10.1016/j.clp.2021.03.002
Hsueh, W. et al. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr. Dev. Pathol. 6, 6–23 (2003).
pubmed: 12424605
doi: 10.1007/s10024-002-0602-z
Gordon, P. V. & Swanson, J. R. Necrotizing enterocolitis is one disease with many origins and potential means of prevention. Pathophysiology 21, 13–19 (2014).
pubmed: 24370207
doi: 10.1016/j.pathophys.2013.11.015
Assad, M. et al. Dilemmas in establishing preterm enteral feeding: where do we start and how fast do we go? J. Perinatol. 43, 1194–1199 (2023).
pubmed: 37169912
doi: 10.1038/s41372-023-01665-w
Bernhard, W. et al. Choline concentrations are lower in postnatal plasma of preterm infants than in cord plasma. Eur. J. Nutr. 54, 733–741 (2015).
pubmed: 25148882
doi: 10.1007/s00394-014-0751-7
Bernhard, W. et al. Choline supply of preterm infants: assessment of dietary intake and pathophysiological considerations. Eur. J. Nutr. 52, 1269–1278 (2013).
pubmed: 22961562
doi: 10.1007/s00394-012-0438-x
Carlson, S. E., Montalto, M. B., Ponder, D. L., Werkman, S. H. & Korones, S. B. Lower incidence of necrotizing enterocolitis in infants fed a preterm formula with egg phospholipids. Pediatr. Res. 44, 491 (1998).
pubmed: 9773836
doi: 10.1203/00006450-199810000-00005
Drenckpohl, D., McConnell, C., Gaffney, S., Niehaus, M. & Macwan, K. S. Randomized trial of very low birth weight infants receiving higher rates of infusion of intravenous fat emulsions during the first week of life. Pediatrics 122, 743–751 (2008).
pubmed: 18829797
doi: 10.1542/peds.2007-2282
Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference I, its Panel on Folate OBV, Choline. The National Academies Collection: Reports funded by National Institutes of Health. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B(6), Folate, Vitamin B(12), Pantothenic Acid, Biotin, and Choline. National Academies Press (US) Copyright © 1998, National Academy of Sciences (1998).
Li, Z. & Vance, D. E. Phosphatidylcholine and choline homeostasis. J. Lipid Res. 49, 1187–1194 (2008).
pubmed: 18204095
doi: 10.1194/jlr.R700019-JLR200
Cornell, R. B. & Ridgway, N. D. CTP:phosphocholine cytidylyltransferase: function, regulation, and structure of an amphitropic enzyme required for membrane biogenesis. Prog. Lipid Res. 59, 147–171 (2015).
pubmed: 26165797
doi: 10.1016/j.plipres.2015.07.001
Zeisel, S. H., Klatt, K. C. & Caudill, M. A. Choline. Adv. Nutr. 9, 58–60 (2018).
pubmed: 29438456
pmcid: 6008955
doi: 10.1093/advances/nmx004
Day, C. R. & Kempson, S. A. Betaine chemistry, roles, and potential use in liver disease. Biochim. Biophys. Acta 1860, 1098–1106 (2016).
pubmed: 26850693
doi: 10.1016/j.bbagen.2016.02.001
Goss, K. C. W. et al. Postnatal adaptations of phosphatidylcholine metabolism in extremely preterm infants: implications for choline and PUFA metabolism. Am. J. Clin. Nutr. 112, 1438–1447 (2020).
pubmed: 32778895
pmcid: 7727469
doi: 10.1093/ajcn/nqaa207
Holmes-McNary, M. Q., Cheng, W. L., Mar, M. H., Fussell, S., Zeisel, S. H. Choline and choline esters in human milk and rat milk and in infant formulas. Am. J. Clin. Nutr. 64 https://doi.org/10.1093/ajcn/64.4.572 (1996).
Food, IoM, Intakes NBSCotSEoDR. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. National Academy Press Washington, DC (2000).
Bernhard, W. et al. Combined choline and DHA supplementation: a randomized controlled trial. Eur. J. Nutr. 59, 729–739 (2020).
pubmed: 30859363
doi: 10.1007/s00394-019-01940-7
Agostoni, C. et al. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr. 50, 85–91 (2010).
pubmed: 19881390
doi: 10.1097/MPG.0b013e3181adaee0
Nilsson, Å., Duan, R. D. & Ohlsson, L. Digestion and absorption of milk phospholipids in newborns and adults. Front. Nutr. 8, 724006 (2021).
pubmed: 34490332
pmcid: 8417471
doi: 10.3389/fnut.2021.724006
Sentongo, T. A. et al. Whole-blood-free choline and choline metabolites in infants who require chronic parenteral nutrition therapy. J. Pediatr. Gastroenterol. Nutr. 50, 194–199 (2010).
pubmed: 20038853
doi: 10.1097/MPG.0b013e3181a93735
Nilsson, A. K. et al. Serum choline in extremely preterm infants declines with increasing parenteral nutrition. Eur. J. Nutr. 60, 1081–1089 (2021).
pubmed: 32588218
doi: 10.1007/s00394-020-02312-2
Maas, C. et al. Choline and polyunsaturated fatty acids in preterm infants’ maternal milk. Eur. J. Nutr. 56, 1733–1742 (2017).
pubmed: 27164830
doi: 10.1007/s00394-016-1220-2
Zeisel, S. H., Char, D. & Sheard, N. F. Choline, phosphatidylcholine and sphingomyelin in human and bovine milk and infant formulas. J. Nutr. 116, 50–58 (1986).
pubmed: 3944656
doi: 10.1093/jn/116.1.50
Shunova, A., et al. Choline content of term and preterm infant formulae compared to expressed breast milk—how do we justify the discrepancies? Nutrients 12 https://doi.org/10.3390/nu12123815 (2020).
Premkumar, M. H., Pammi, M., Suresh, G. Human milk-derived fortifier versus bovine milk-derived fortifier for prevention of mortality and morbidity in preterm neonates. Cochrane Database Syst, Rev. https://doi.org/10.1002/14651858.CD013145.pub2 (2019).
Ananthan, A., Balasubramanian, H., Rao, S. & Patole, S. Human milk-derived fortifiers compared with bovine milk-derived fortifiers in preterm infants: a systematic review and meta-analysis. Adv. Nutr. 11, 1325–1333 (2020).
pubmed: 32277813
pmcid: 7490161
doi: 10.1093/advances/nmaa039
Koo, W. & Tice, H. Human milk fortifiers do not meet the current recommendation for nutrients in very low birth weight infants. J. Parenter. Enter. Nutr. 42, 813–820 (2018).
doi: 10.1177/0148607117713202
Bernhard, W., Poets, C. F. & Franz, A. R. Choline and choline-related nutrients in regular and preterm infant growth. Eur. J. Nutr. 58, 931–945 (2019).
pubmed: 30298207
doi: 10.1007/s00394-018-1834-7
Ozarda Ilcol, Y., Uncu, G. & Ulus, I. H. Free and phospholipid-bound choline concentrations in serum during pregnancy, after delivery and in newborns. Arch. Physiol. Biochem. 110, 393–399 (2002).
pubmed: 12530624
doi: 10.1076/apab.110.5.393.11832
Crawford, S. A., et al. Micronutrient gaps and supplement use in a diverse cohort of pregnant women. Nutrients. 15 https://doi.org/10.3390/nu15143228 (2023).
Carmichael, S. L., Yang, W. & Shaw, G. M. Maternal dietary nutrient intake and risk of preterm delivery. Am. J. Perinatol. 30, 579–588 (2013).
pubmed: 23208764
Zhu, J. et al. Dietary choline intake during pregnancy and PEMT rs7946 polymorphism on risk of preterm birth: a case-control study. Ann. Nutr. Metab. 76, 431–440 (2020).
pubmed: 33503637
doi: 10.1159/000507472
Wilson, R. B. Nutrient deficiencies in animals: Choline. Handbook Series in Nutrition and Food, Section E: Nutritional Disorders, Vol II. (1978).
Nilsson, Å. & Duan, R. D. Pancreatic and mucosal enzymes in choline phospholipid digestion. Am. J. Physiol. Gastrointest. Liver Physiol. 316, G425–g445 (2019).
pubmed: 30576217
doi: 10.1152/ajpgi.00320.2018
da Silva, R. P. et al. Choline deficiency impairs intestinal lipid metabolism in the lactating rat. J. Nutr. Biochem. 26, 1077–1083 (2015).
pubmed: 26092371
doi: 10.1016/j.jnutbio.2015.04.015
Bressenot, A. et al. Methyl donor deficiency affects small-intestinal differentiation and barrier function in rats. Br. J. Nutr. 109, 667–677 (2013).
pubmed: 22794784
doi: 10.1017/S0007114512001869
Woo, H. D. et al. Dietary patterns in children with attention deficit/hyperactivity disorder (ADHD). Nutrients 6, 1539–1553 (2014).
pubmed: 24736898
pmcid: 4011050
doi: 10.3390/nu6041539
Wu, P. et al. Dietary choline deficiency and excess induced intestinal inflammation and alteration of intestinal tight junction protein transcription potentially by modulating NF-κB, STAT and p38 MAPK signaling molecules in juvenile Jian carp. Fish. Shellfish Immunol. 58, 462–473 (2016).
pubmed: 27693201
doi: 10.1016/j.fsi.2016.09.055
Matthews, D. R. et al. Methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis is associated with increased intestinal inflammation. Am. J. Pathol. 191, 1743–1753 (2021).
pubmed: 34242656
pmcid: 8485057
doi: 10.1016/j.ajpath.2021.06.010
Yan, J. K. et al. Supplementary choline attenuates olive oil lipid emulsion-induced enterocyte apoptosis through suppression of CELF1/AIF pathway. J. Cell Mol. Med. 22, 1562–1573 (2018).
pubmed: 29105957
doi: 10.1111/jcmm.13430
Stremmel, W., Hanemann, A., Ehehalt, R., Karner, M. & Braun, A. Phosphatidylcholine (lecithin) and the mucus layer: evidence of therapeutic efficacy in ulcerative colitis? Dig. Dis. 28, 490–496 (2010).
pubmed: 20926877
doi: 10.1159/000320407
Feldens, L., Souza, J. C. K. & Fraga, J. C. There is an association between disease location and gestational age at birth in newborns submitted to surgery due to necrotizing enterocolitis. J. Pediatr. 94, 320–324 (2018).
doi: 10.1016/j.jped.2017.06.010
Böckmann, K. A. et al. Choline supplementation for preterm infants: metabolism of four Deuterium-labeled choline compounds. Eur. J. Nutr. 62, 1195–1205 (2023).
pubmed: 36460779
doi: 10.1007/s00394-022-03059-8
Farrell, P. M., Epstein, M. F., Fleischman, A. R., Oakes, G. K., Chez, R. A. Lung lecithin biosynthesis in the nonhuman primate fetus: determination of the primary pathway in vivo. Biol. Neonate. 29 https://doi.org/10.1159/000240869 (1976).
Rusnak, T. et al. A physiologically relevant dose of 50% egg-phosphatidylcholine is sufficient in improving gut permeability while attenuating immune cell dysfunction induced by a high-fat diet in male Wistar rats. J. Nutr. 153, 3131–3143 (2023).
pubmed: 37586605
doi: 10.1016/j.tjnut.2023.08.010
Andrew, M. J. et al. Optimising nutrition to improve growth and reduce neurodisabilities in neonates at risk of neurological impairment, and children with suspected or confirmed cerebral palsy. BMC Pediatr. 15, 22 (2015).
pubmed: 25885548
pmcid: 4389808
doi: 10.1186/s12887-015-0339-2
Andrew, M. J. et al. Neurodevelopmental outcome of nutritional intervention in newborn infants at risk of neurodevelopmental impairment: the Dolphin neonatal double-blind randomized controlled trial. Dev. Med. Child Neurol. 60, 897–905 (2018).
pubmed: 29806081
doi: 10.1111/dmcn.13914
Andrew, M. J. et al. Nutritional intervention and neurodevelopmental outcome in infants with suspected cerebral palsy: the Dolphin infant double-blind randomized controlled trial. Dev. Med. Child Neurol. 60, 906–913 (2018).
pubmed: 29023666
doi: 10.1111/dmcn.13586
Cetinkaya, M. et al. CDP-choline reduces severity of intestinal injury in a neonatal rat model of necrotizing enterocolitis. J. Surg. Res 183, 119–128 (2013).
pubmed: 23228325
doi: 10.1016/j.jss.2012.11.032
Thomaidou, A., et al. A prospective, case-control study of serum metabolomics in neonates with late-onset sepsis and necrotizing enterocolitis. J. Clin. Med. 11 https://doi.org/10.3390/jcm11185270 (2022).
Innis, S. M., Davidson, A. G., Bay, B. N., Slack, P. J. & Hasman, D. Plasma choline depletion is associated with decreased peripheral blood leukocyte acetylcholine in children with cystic fibrosis. Am. J. Clin. Nutr. 93, 564–568 (2011).
pubmed: 21228267
doi: 10.3945/ajcn.110.005413
Bean, J. W., Sidky, M. M. Intestinal blood flow as influenced by vascular and motor reactions to acetylcholine and carbon dioxide. Am. J. Physiol. 1958;194 https://doi.org/10.1152/ajplegacy.1958.194.3.512 (1958).
Sengupta, S., Piotrowski, E., Slomiany, A., Slomiany, B. L. Role of adrenergic and cholinergic mediators in gastric mucus phospholipid secretion. Biochem. Int. 1991;24 (1991).
de Araujo, A. & de Lartigue, G. Non-canonical cholinergic anti-inflammatory pathway in IBD. Nat. Rev. Gastroenterol. Hepatol. 17, 651–652 (2020).
pubmed: 32759984
pmcid: 7826200
doi: 10.1038/s41575-020-0356-y
Simon, T. et al. The cholinergic anti-inflammatory pathway inhibits inflammation without lymphocyte relay. Front. Neurosci. 17, 1125492 (2023).
pubmed: 37123375
pmcid: 10140439
doi: 10.3389/fnins.2023.1125492
Wu, C. C., Chen, S. J., Yen, M. H. Loss of acetylcholine-induced relaxation by M-3 receptor activation in mesenteric arteries of spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 30 https://doi.org/10.1097/00005344-199708000-00015 (1997).
Watkins, D. J. & Besner, G. E. The role of the intestinal microcirculation in necrotizing enterocolitis. Semin. Pediatr. Surg. 22, 83–87 (2013).
pubmed: 23611611
pmcid: 3646103
doi: 10.1053/j.sempedsurg.2013.01.004
Nowicki, P. T. Ischemia and necrotizing enterocolitis: where, when, and how. Semin Pediatr. Surg. 14, 152–158 (2005).
pubmed: 16084402
doi: 10.1053/j.sempedsurg.2005.05.003
Beach, R. C., Menzies, I. S., Clayden, G. S., Scopes, J. W. Gastrointestinal permeability changes in the preterm neonate. Arch. Dis. Child. 57 https://doi.org/10.1136/adc.57.2.141 (1982).
Edelstone, D.I., Holzman, I.R. Fetal and neonatal intestinal circulations. In: Shepherd, A.P., Granger, D.N. (eds.) Physiology of the Intestinal Circulation. 181–190 (Raven Press, New York, 1984).
Caplan, M. S., Adler, L., Kelly, A. & Hsueh, W. Hypoxia increases stimulus-induced PAF production and release from human umbilical vein endothelial cells. Biochim. Biophys. Acta 1128, 205–210 (1992).
pubmed: 1420292
doi: 10.1016/0005-2760(92)90309-J
Qu, X. et al. Endotoxin induces PAF production in the rat ileum: quantitation of tissue PAF by an improved method. Prostaglandins 51, 249–262 (1996).
pubmed: 8935185
doi: 10.1016/0090-6980(96)00020-2
Caplan, M. S., Simon, D. & Jilling, T. The role of PAF, TLR, and the inflammatory response in neonatal necrotizing enterocolitis. Semin. Pediatr. Surg. 14, 145–151 (2005).
pubmed: 16084401
doi: 10.1053/j.sempedsurg.2005.05.002
Bar-Natan, M. F., Wilson, M. A., Spain, D. A. & Garrison, R. N. Platelet-activating factor and sepsis-induced small intestinal microvascular hypoperfusion. J. Surg. Res. 58, 38–45 (1995).
pubmed: 7830404
doi: 10.1006/jsre.1995.1007
Chatterton, D. E., Nguyen, D. N., Bering, S. B. & Sangild, P. T. Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns. Int. J. Biochem. Cell Biol. 45, 1730–1747 (2013).
pubmed: 23660296
doi: 10.1016/j.biocel.2013.04.028
Anto, L., Warykas, S. W., Torres-Gonzalez, M., Blesso, C. N. Milk polar lipids: underappreciated lipids with emerging health benefits. Nutrients 12 https://doi.org/10.3390/nu12041001 (2020).
Tongviratskool, C. et al. How does human milk protect against necrotizing enterocolitis (NEC)? Targeted validation and time-course analysis of 35 gene responses as NEC-signature in fetal intestinal epithelial cells. Omics 26, 440–450 (2022).
pubmed: 35900271
doi: 10.1089/omi.2022.0075
Ewer, A. K. et al. The role of platelet-activating factor in a neonatal piglet model of necrotising enterocolitis. Gut 53, 207–213 (2004).
pubmed: 14724152
pmcid: 1774938
doi: 10.1136/gut.2003.024521
Palleri, E. et al. Clinical usefulness of splanchnic oxygenation in predicting necrotizing enterocolitis in extremely preterm infants: a cohort study. BMC Pediatr. 23, 336 (2023).
pubmed: 37393233
pmcid: 10314466
doi: 10.1186/s12887-023-04145-4
Özkan, H., Çetinkaya, M., Dorum, B. A. & Köksal, N. Mesenteric tissue oxygenation status on the development of necrotizing enterocolitis. Turk. J. Pediatr. 63, 811–817 (2021).
pubmed: 34738363
doi: 10.24953/turkjped.2021.05.009
Murdoch, E. M., Sinha, A. K., Shanmugalingam, S. T., Smith, G. C. & Kempley, S. T. Doppler flow velocimetry in the superior mesenteric artery on the first day of life in preterm infants and the risk of neonatal necrotizing enterocolitis. Pediatrics 118, 1999–2003 (2006).
pubmed: 17079572
doi: 10.1542/peds.2006-0272
Yue, G. et al. Prediction of necrotizing enterocolitis in very low birth weight infants by superior mesenteric artery ultrasound of postnatal day 1: a nested prospective study. Front. Pediatr. 10, 1102238 (2022).
pubmed: 36727003
doi: 10.3389/fped.2022.1102238
Kovács, T. et al. Dietary phosphatidylcholine supplementation attenuates inflammatory mucosal damage in a rat model of experimental colitis. Shock 38, 177–185 (2012).
pubmed: 22576006
doi: 10.1097/SHK.0b013e31825d1ed0
Ghyczy, M. et al. Oral phosphatidylcholine pretreatment decreases ischemia-reperfusion-induced methane generation and the inflammatory response in the small intestine. Shock 30, 596–602 (2008).
pubmed: 18461026
doi: 10.1097/SHK.0b013e31816f204a
Tokés, T. et al. Protective effects of a phosphatidylcholine-enriched diet in lipopolysaccharide-induced experimental neuroinflammation in the rat. Shock 36, 458–465 (2011).
pubmed: 21937953
doi: 10.1097/SHK.0b013e31822f36b0
Tőkés, T. et al. Protective effects of L-alpha-glycerylphosphorylcholine on ischaemia-reperfusion-induced inflammatory reactions. Eur. J. Nutr. 54, 109–118 (2015).
pubmed: 24682350
doi: 10.1007/s00394-014-0691-2
Gatt, M. et al. Changes in superior mesenteric artery blood flow after oral, enteral, and parenteral feeding in humans. Crit. Care Med. 37, 171–176 (2009).
pubmed: 19050615
doi: 10.1097/CCM.0b013e318192fb44
Maas, C. et al. A historic cohort study on accelerated advancement of enteral feeding volumes in very premature infants. Neonatology 103, 67–73 (2013).
pubmed: 23095283
doi: 10.1159/000342223
Oddie, S. J., Young, L. & McGuire, W. Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst. Rev. 8, Cd001241 (2021).
pubmed: 34427330
Bjornvad, C. R. et al. Enteral feeding induces diet-dependent mucosal dysfunction, bacterial proliferation, and necrotizing enterocolitis in preterm pigs on parenteral nutrition. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G1092–G1103 (2008).
pubmed: 18818317
doi: 10.1152/ajpgi.00414.2007
Teratani, T. et al. The liver-brain-gut neural arc maintains the T(reg) cell niche in the gut. Nature 585, 591–596 (2020).
pubmed: 32526765
doi: 10.1038/s41586-020-2425-3
Till, H., Castellani, C., Moissl-Eichinger, C., Gorkiewicz, G. & Singer, G. Disruptions of the intestinal microbiome in necrotizing enterocolitis, short bowel syndrome, and Hirschsprung’s associated enterocolitis. Front. Microbiol. 6, 1154 (2015).
pubmed: 26528281
pmcid: 4607865
doi: 10.3389/fmicb.2015.01154
Kim, C. S. & Claud, E. C. Necrotizing enterocolitis pathophysiology: how microbiome data alter our understanding. Clin. Perinatol. 46, 29–38 (2019).
pubmed: 30771817
doi: 10.1016/j.clp.2018.10.003
Pammi, M. et al. Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis. Microbiome 5, 31 (2017).
pubmed: 28274256
pmcid: 5343300
doi: 10.1186/s40168-017-0248-8
Gudan A., Kozłowska-Petriczko K., Wunsch E., Bodnarczuk T., Stachowska E. Small intestinal bacterial overgrowth and non-alcoholic fatty liver disease: what do we know in 2023? Nutrients 15 https://doi.org/10.3390/nu15061323 (2023).
Romano, K. A. et al. Metabolic, epigenetic, and transgenerational effects of gut bacterial choline consumption. Cell Host Microbe 22, 279–290.e7 (2017).
pubmed: 28844887
pmcid: 5599363
doi: 10.1016/j.chom.2017.07.021
Qiu, Y. et al. Supplemental choline modulates growth performance and gut inflammation by altering the gut microbiota and lipid metabolism in weaned piglets. J. Nutr. 151, 20–29 (2021).
pubmed: 33245135
doi: 10.1093/jn/nxaa331
Zhan, X. et al. Choline supplementation regulates gut microbiome diversity, gut epithelial activity, and the cytokine gene expression in gilts. Front. Nutr. 10, 1101519 (2023).
pubmed: 36819695
pmcid: 9931747
doi: 10.3389/fnut.2023.1101519
Zhang, M. et al. Choline supplementation during pregnancy protects against gestational lipopolysaccharide-induced inflammatory responses. Reprod. Sci. 25, 74–85 (2018).
pubmed: 28436303
doi: 10.1177/1933719117702247
Stremmel, W. et al. Mucosal protection by phosphatidylcholine. Dig. Dis. 30, 85–91 (2012).
pubmed: 23295697
doi: 10.1159/000342729
AlFaleh, K., Anabrees, J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. Cd005496. https://doi.org/10.1002/14651858.CD005496.pub4 (2014).
Al Mutairi, F. Hyperhomocysteinemia: clinical Insights. J. Cent. Nerv. Syst. Dis. 12, 1179573520962230 (2020).
pubmed: 33100834
pmcid: 7549175
doi: 10.1177/1179573520962230
Danese, S. et al. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am. J. Gastroenterol. 100, 886–895 (2005).
pubmed: 15784037
doi: 10.1111/j.1572-0241.2005.41469.x
Munjal, C. et al. Mesenteric vascular remodeling in hyperhomocysteinemia. Mol. Cell Biochem. 348, 99–108 (2011).
pubmed: 21076854
doi: 10.1007/s11010-010-0643-y
Smith, R. M., Rai, S., Kruzliak, P., Hayes, A. & Zulli, A. Putative Nox2 inhibitors worsen homocysteine-induced impaired acetylcholine-mediated relaxation. Nutr. Metab. Cardiovasc. Dis. 29, 856–864 (2019).
pubmed: 31272869
doi: 10.1016/j.numecd.2019.05.051
Alexander, T., Rajnish, R., Balakrishnan, R. & Shallam, J. F. Hyperhomocysteinemia presenting as superior mesenteric artery thrombosis. Indian J. Gastroenterol. 24, 78–79 (2005).
pubmed: 15879660
Bala, R., Verma, R., Budhwar, S., Prakash, N. & Sachan, S. Fetal hyperhomocysteinemia is associated with placental inflammation and early breakdown of maternal-fetal tolerance in pre-term birth. Am. J. Reprod. Immunol. 88, e13589 (2022).
pubmed: 35750632
doi: 10.1111/aji.13589
Papa, A. et al. Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease. Am. J. Gastroenterol. 96, 2677–2682 (2001).
pubmed: 11569694
doi: 10.1111/j.1572-0241.2001.04127.x
Whittle, B. J. R., Vane, J. R. Prostanoids as regulators of gastrointestinal function. Physiology of the Gastrointestinal Tract, 2nd Ed. (Raven Press, New York, 1987).
Wilson, D. E. Role of prostaglandins in gastroduodenal mucosal protection. J. Clin. Gastroenterol. 13 https://doi.org/10.1097/00004836-199112001-00011 (1991).
Hart, M. H., Grandjean, C. J., Park, J. H. Y., Erdman, S. H., Vanderhoof, J. A. Essential fatty acid deficiency and postresection mucosal adaptation in the rat. Gastroenterology 94 https://doi.org/10.1016/0016-5085(88)90239-9 (1988).
Allen, A., Flemstrom, G., Garner, A., Kivilasskso, E. Gastroduodenal mucosal protection. Physiol. Rev. 73 https://doi.org/10.1152/physrev.1993.73.4.823 (1993).
Scheiman, J. M., Kraus, E. R., Bonnville, L. A., Weinhold, P. A., Boland, C. R. Synthesis and prostaglandin E2-induced secretion of surfactant phospholipid by isolated gastric mucous cells. Gastroenterology 100 https://doi.org/10.1016/0016-5085(91)70009-M (1991).
Kao, Y. C. J., Lichtenberger, L. M. A method to preserve extracellular surfactant-like phospholipids on the luminal surface of the rodent gastric mucosa. J. Histochem. Cytochem. 38 https://doi.org/10.1177/38.3.1689341 (1990).
Caplan, M. S. et al. Effect of polyunsaturated fatty acid (PUFA) supplementation on intestinal inflammation and necrotizing enterocolitis (NEC) in a neonatal rat model. Pediatr. Res. 49, 647–652 (2001).
pubmed: 11328947
doi: 10.1203/00006450-200105000-00007
Caplan, M. S. & Jilling, T. The role of polyunsaturated fatty acid supplementation in intestinal inflammation and neonatal necrotizing enterocolitis. Lipids 36, 1053–1057 (2001).
pubmed: 11724457
doi: 10.1007/s11745-001-0816-3
Alshaikh, B. N. et al. Enteral long-chain polyunsaturated fatty acids and necrotizing enterocolitis: a systematic review and meta-analysis. Am. J. Clin. Nutr. 117, 918–929 (2023).
pubmed: 37137615
doi: 10.1016/j.ajcnut.2023.01.007